Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Locations have been expanded and reorganized to include numerous sites across the United States and internationally. Several regional location groupings were removed, and the revision label now shows v3.3.3.
    Difference
    2%
    Check dated 2025-12-19T15:25:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Site revision updated to v3.3.2; the previous revision v3.3.1 has been removed.
    Difference
    0.0%
    Check dated 2025-11-28T01:19:47.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Publications section now notes that entries are automatically filled from PubMed and may not all pertain to the study, and the revision tag was updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:15:29.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Removed the site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status from the page; the study details and linked trial information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-13T15:48:48.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Added Cali, Valle del Cauca Department, Colombia, 760032 as a study location. Removed Santiago de Cali, Valle del Cauca Department, Colombia, 760032 as a study location.
    Difference
    0.2%
    Check dated 2025-10-30T09:20:15.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Updated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.
    Difference
    0.0%
    Check dated 2025-10-01T02:37:22.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.